scispace - formally typeset
Open AccessJournal ArticleDOI

The landscape of somatic copy-number alteration across human cancers

Rameen Beroukhim, +86 more
- 18 Feb 2010 - 
- Vol. 463, Iss: 7283, pp 899-905
Reads0
Chats0
TLDR
It is demonstrated that cancer cells containing amplifications surrounding the MCL1 and BCL2L1 anti-apoptotic genes depend on the expression of these genes for survival, and a large majority of SCNAs identified in individual cancer types are present in several cancer types.
Abstract
A powerful way to discover key genes with causal roles in oncogenesis is to identify genomic regions that undergo frequent alteration in human cancers. Here we present high-resolution analyses of somatic copy-number alterations (SCNAs) from 3,131 cancer specimens, belonging largely to 26 histological types. We identify 158 regions of focal SCNA that are altered at significant frequency across several cancer types, of which 122 cannot be explained by the presence of a known cancer target gene located within these regions. Several gene families are enriched among these regions of focal SCNA, including the BCL2 family of apoptosis regulators and the NF-kappaBeta pathway. We show that cancer cells containing amplifications surrounding the MCL1 and BCL2L1 anti-apoptotic genes depend on the expression of these genes for survival. Finally, we demonstrate that a large majority of SCNAs identified in individual cancer types are present in several cancer types.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration

TL;DR: The Integrative Genomics Viewer (IGV) is a high-performance viewer that efficiently handles large heterogeneous data sets, while providing a smooth and intuitive user experience at all levels of genome resolution.
Journal ArticleDOI

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

TL;DR: The results indicate that large, annotated cell-line collections may help to enable preclinical stratification schemata for anticancer agents and the generation of genetic predictions of drug response in the preclinical setting and their incorporation into cancer clinical trial design could speed the emergence of ‘personalized’ therapeutic regimens.
Journal ArticleDOI

Integrated genomic analyses of ovarian carcinoma

Debra A. Bell, +285 more
- 30 Jun 2011 - 
TL;DR: It is reported that high-grade serous ovarian cancer is characterized by TP53 mutations in almost all tumours (96%); low prevalence but statistically recurrent somatic mutations in nine further genes including NF1, BRCA1,BRCA2, RB1 and CDK12; 113 significant focal DNA copy number aberrations; and promoter methylation events involving 168 genes.

Integrated genomic analyses of ovarian carcinoma

Daphne W. Bell, +261 more
TL;DR: The Cancer Genome Atlas project has analyzed messenger RNA expression, microRNA expression, promoter methylation and DNA copy number in 489 high-grade serous ovarian adenocarcinomas and the DNA sequences of exons from coding genes in 316 of these tumours as mentioned in this paper.
References
More filters
Journal ArticleDOI

Analysis of array CGH data: from signal ratio to gain and loss of DNA regions

TL;DR: A methodology for the automatic detection of breakpoints from array CGH profile, and the assignment of a status to each chromosomal region, based on the Adaptive Weights Smoothing procedure is developed.
Journal ArticleDOI

Diagnosing and exploiting cancer's addiction to blocks in apoptosis

TL;DR: This work has shown that it is possible to systematically determine how individual cancers escape apoptosis, and this determination can help predict not only whether cells are likely to be killed by antagonism of BCL2, but also whether they are sensitive to chemotherapy that kills by the intrinsic apoptotic pathway.
Journal ArticleDOI

Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells.

TL;DR: In this article, the authors used high-throughput RNA interference (RNAi) to identify synthetic lethal interactions in cancer cells harboring mutant KRAS, the most commonly mutated human oncogene, and demonstrate the potential of RNAi screens for discovering functional dependencies created by oncogenic mutations that may enable therapeutic intervention for cancers with "undruggable" genetic alterations.
Journal ArticleDOI

PTEN-deficient cancers depend on PIK3CB

TL;DR: Although p110α activation is required to sustain the proliferation of established PIK3CA-mutant tumors, PTEN-deficient tumors are dependent instead on p110β signaling, demonstrating the need to tailor therapeutic approaches to the genetic basis of PI3K pathway activation to achieve optimal treatment response.
Related Papers (5)

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

Roger E. McLendon, +233 more
- 23 Oct 2008 -